Pyrogen Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product & Service (Assays Kits & Reagents, Instruments, Services), By Test Type (LAL Tests, In Vitro Tests, Rabbit Tests), By End-User (Pharmaceutical & Biotechnology Companies, Medical Device Companies, Other End Users) and Region Forecast 2020-2031

Pyrogen Testing Market size was valued at US$ 1,640.6 million in 2024 and is expected to reach US$ 3,741.7 million by 2031, growing at a significant CAGR of 12.5% from 2025-2031. Pyrogen testing is essential in modern healthcare since it detects the presence of pyrogen in an organism that causes fever. Pyrogen can be present in lipopolysaccharides and lipoteichoic acid. Contaminated pyrogenic can cause severe harmful consequences in the human body, such as fever. Based on product and service, the market is segmented into assays, kits & reagents, instruments, and services.

The assays, kits, and reagents category held the most significant proportion of the market. The growing demand for kit-based testing and the frequent need for immunoassays, kits, and reagents in large quantities as opposed to equipment are the primary reasons driving the expansion of this category. Moreover, market players are focusing on launching new products, acquisitions, and collaboration. For instance, Lonza, a multinational manufacturing company for pharmaceutical & biotechnology, Launches the Pyro Cell Monocyte Activation Test System for reliable and sustainable in vitro pyrogen testing. The growing pharmaceutical, biotechnology, and medical devices industries, increased R&D investment, and favorable government policies are some drivers driving the global market in the forecasting period.

Key Developments:

• In April 2021, US-based Associates of Cape Cod, Inc. (ACC), Specializing in chromogenic and turbidimetric reagent technologies, launched its new, innovative product called Pyro Smart NextGen for Bacterial Endotoxin Testing (BET).